Home RxNorm 2719474 Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2719474
RxNorm name Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension
Display name Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension
Full name Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension
Term type PSN
Status DailyMed mapping
Updated 2026-06-04 23:39:06 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 103914 Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent Influenza Virus Vaccine 351(a) Rx 2026-07-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 8213c229-a67a-4d3f-bd8f-b8729ae28472 Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension [PSN] · influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2025-2026] [SBD] · Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension [SY] 3 25 These highlights do not include all the information needed to use Fluzone ® Quadrivalent safely and effectively. See full prescribing information for Fluzone Quadrivalent. Fluzone Quadrivalent (Influenza Vaccine) injectable suspension, for intramuscular use 2025-2026 Formula Initial U.S. Approval: 2013 20250711